Orthologic Corp
Pharmaceuticals - , Texas, United States
Orthologic Corp Senior Management
Orthologic Corp Details
Capstone Therapeutics (OTCQB: CAPS) is a clinical stage biotechnology company developing a family of new peptide drugs to serve cardiovascular patients with high cholesterol and triglyceride levels otherwise unaddressable through standard therapy. Capstone holds an FDA Orphan drug designation for its lead molecule, AEM-28, for Homozygous Familial Hypercholesterolemia (HoFH) and may also target indications in acute coronary syndrome, peripheral artery disease and type 2 diabetes.
Website:
capstonethx.com
Employees:
11 - 50
HQ:
Location:
, Texas, United States
Revenue:
Orthologic Corp Technologies
Email Providers
Outlook
CMS
WordPress.org
Fonts
Google Font API
Other
Microsoft Office 365
Hosting
Flywheel